2 Figure Table S1 10 Table S2 11-12 Figure S1: Kaplan-Meier analysis showing time on treatment with first-line ARSI for SPOP wild-type and SPOP-mutated tumors. P-value was generated from the logrank statistic. Figure S2 : Kaplan-Meier analysis showing overall survival and time on treatment with first-line ARSI for diploid and aneuploid tumors. P-value was generated from the logrank statistic. Figure S3 : AR-V7 levels in relation to prior treatment exposure. AR-V7 level detected in PolyA libraries as ratio of AR-V7 reads / AR promoter 1-2 (Left) and as splice reads per million (SRPM) (Right) in relation to ARSI and taxane treatment exposure. AR-V7 expression is higher in tumors exposed to both an ARSI and a taxane relative to tumors that are naïve to both agents. P-values were generated using unpaired t-tests. Table S2 : Pathway classifications of genes altered in mCRPC. Indicated are gene names, pathway in which the gene/protein is functional based on current knowledge, and gene alterations that are considered potentially biologically-relevant for that gene.
